However, to fully realize its potential in clinical and functional food applications, future research should delve more deeply into the molecular mechanisms through which N. gaditana lipids modulate hyperlipidemia-related signaling pathways (such as PPAR-α, SREBP, or LDL receptor pathways) and conduct comprehensive safety assessments of N. gaditana lipids. This evidence concerns the gene LDLR and hyperlipidemia.